Procurement Summary
Country: USA
Summary: Covalent Screening Library of Small Molecules
Deadline: 10 Sep 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 125760760
Document Ref. No.: 75N95025Q00247
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Description
(i) This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95025Q00247 and the solicitation is issued as a request for quotation (RFQ)
This acquisition is for a commercial product or commercial service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Products and Commercial Services and is not expected to exceed the simplified acquisition threshold.
The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2025-05, with effective date August 7, 2025.
The associated NAICS code 32599 and the small business size standard is 650 Employees. This requirement has no set aside restrictions and will be solicited as full and open competition.
This requirement is for the following custom covalent library.
Purpose and Objectives: NCATS ETB is looking to expand its covalent screening library of small molecules. Adding diversity to chemical libraries is imperative to our operation, as we screen a variety of targets against these in-house collections.
The current DPI compound collection notably lacks a collection of custom covalent libraries. Covalent inhibitors offer several advantages, including the ability to target proteins considered undruggable in live cells, the development of novel affinity-based probes, enhanced potency, and prolonged duration of action. This approach is particularly appealing in both medicinal chemistry and chemical biology research. Acquiring these compounds is imperative to development of a focused, ...
Active Contract Opportunity
Notice ID : 75N95025Q00247
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
Original Published Date: Sep 04, 2025 09:47 pm EDT
Original Date Offers Due: Sep 10, 2025 12:00 pm EDT
Inactive Policy: Manual
Original Inactive Date: Sep 11, 2025
Initiative: None
Classification
Original Set Aside: No Set aside used
Product Service Code: 6810 - CHEMICALS
NAICS Code: 32599 - All Other Chemical Product and Preparation Manufacturing
Place of Performance: MD 20850 USA
Documents
Tender Notice
Comb_Synop-Solicit-COMPETITIVE.pdf